Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Knechtle, Stuart
ADAPT, NCT05017545: Carfilzomib and Belatacept for Desensitization	Recruiting	1/2	15	US	carfilzomib, Kyprolis®, belatacept, Nulojix®, Bone marrow aspiration	National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), Bristol-Myers Squibb, PPD, Rho Federal Systems Division, Inc.	Highly Sensitized Prospective Kidney Transplant Recipients	02/27	02/28
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25